XML 59 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the components of stock-based compensation expense in the condensed consolidated statements of operations
The following table summarizes the components of stock-based compensation expense in the consolidated statements of (loss) income for the twelve months ended December 31, 2016:
 
(in thousands)
Amount
Selling, general, and administrative expenses
$
3,423

Research and development expenses
261

Total
$
3,684



The following table summarizes the components of stock-based compensation expense in the consolidated statements of (loss) income for the five months ended December 31, 2015:
 
(in thousands)
Amount
Selling, general, and administrative expenses
$
1,071

Research and development expenses
53

Total
$
1,124

Summary of the status of time-based stock options
A summary of the status of the Company’s time-based stock options (“Options”) as of December 31, 2016 and the activity since August 1, 2015 is as follows:
 
 
Number of
Shares Underlying Awards
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic Value 
(In thousands)
Outstanding at August 1, 2015

$

0
$

Granted
1,106,875

12.00

9.58

Exercised


0

Forfeited or expired


0

Outstanding at December 31, 2015
1,106,875

12.00

9.58

Exercisable at December 31, 2015


0

Vested and expected to vest at December 31, 2015
1,106,875

$
12.00

9.58
$









Outstanding at January 1, 2016
1,106,875

$
12.00

9.58
$

Granted
167,598

5.37

9.76

Exercised


0

Forfeited or expired
(522,500
)
12.00

0

Outstanding at December 31, 2016
751,973

$
10.52

8.91
$

Exercisable at December 31, 2016


0

Vested and expected to vest at December 31, 2016
751,973

$
10.52

8.91
$

Summary of the time-based SARs
A summary of the Company’s time-based SARs as of December 31, 2016 is as follows:

 
Number
of
Awards
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic Value
(In thousands)
Outstanding at August 1, 2015

$

0
$

Granted
165,000

12.00

9.71

Exercised


0

Forfeited or expired


0

Outstanding at December 31, 2015
165,000

12.00

9.71

Exercisable at December 31, 2015


0

Vested and expected to vest at December 31, 2015
165,000

$
12.00

9.71
$

 
 
 
 
 
Outstanding at January 1, 2016
165,000

$
12.00

9.71
$

Granted


0

Exercised


0

Forfeited or expired
(6,875
)
12.00

0

Outstanding at December 31, 2016
158,125

$
12.00

8.71
$

Exercisable at December 31, 2016


0

Vested and expected to vest at December 31, 2016
158,125

$
12.00

8.71
$

Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of fair value assumptions
 
Year Ended December 31,
2016
August 1, 2015
Through
December 31, 2015
Weighted average grant date fair value
$2.51
$4.03
Risk-free interest rate
1.32%
1.67% - 1.70%
Expected life (years)
6.00
5.73 - 5.97
Estimated volatility factor
48.3%
47.7% - 48.0%
Expected dividends
None
None
Stock appreciation rights (SAR)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of fair value assumptions
 
As of
December 31,
2016
August 1, 2015
Through
December 31, 2015
Fair value of awards
$0.32
$1.74
Risk-free interest rate
1.87%
2.24%-2.25%
Expected life (years)
4.73
6.40-6.54
Estimated volatility factor
54.5%
47.5%-47.7%
Expected dividends
None
None
Restricted stock units (RSU)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of unvested performance shares
A summary of the Company’s restricted stock awards as of December 31, 2016 and the activity since August 1, 2015 is as follows:
 
 
Number of
Shares
Weighted-Average
Grant Date Fair 
Value
Non-vested RSUs at August 1, 2015

$

Granted
596,491

6.34

Vested


Forfeited or expired


Non-vested RSUs at December 31, 2015
596,491

$
6.34

 
 
 
Non-vested RSUs at January 1, 2016
596,491

$
6.34

Granted
194,570

5.32

Vested
(354,637
)
6.34

Forfeited or expired
(84,407
)
6.35

Non-vested RSUs at December 31, 2016
352,017

$
5.77

Phantom stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of unvested performance shares
A summary of the Company’s Phantom Stock Awards as of December 31, 2016 is as follows:

 
Number of
Awards
Weighted-Average
Grant Date Fair Value
Non-vested phantom stock awards at August 1, 2015

$

Granted
154,502

6.34

Vested


Forfeited or expired


Non-vested phantom stock awards at December 31, 2015
154,502

$
6.34

 
 
 
Non-vested phantom stock awards at January 1, 2016
154,502

$
6.34

Granted
10,500

6.11

Vested
(49,655
)
6.34

Forfeited or expired
(5,538
)
6.34

Non-vested phantom stock awards at December 31, 2016
109,809

$
6.32

Director shares  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of fair value assumptions
Risk-free interest rate
1.96%
Expected life (years)
6.47
Estimated volatility factor
31.16%
Expected dividends
None
Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of nonvested shares
A summary of the Company’s time-based restricted stock awarded to the Board of Directors for the twelve months ended December 31, 2016 is as follows:

 
Number of
Shares
Weighted-Average
Grant Date Fair Value
Non-vested time-based restricted stocks at August 1, 2015

$

Granted
26,387

6.34

Vested


Forfeited or expired


Non-vested time-based restricted stock at December 31, 2015
26,387

$
6.34

 
 
 
Non-vested time-based restricted stock at January 1, 2016
26,387

$
6.34

Granted
69,539

5.08

Vested
(76,802
)
5.22

Forfeited or expired
(4,600
)
6.34

Non-vested time-based restricted stock at December 31, 2016
14,524

$
6.22